Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-57525
J Alzheimers Dis January 1, 2020; 78 (4): 1661-1678.
Show Gene links Show Anatomy links

Functional Integrity of Synapses in the Central Nervous System of Cognitively Intact Individuals with High Alzheimer''s Disease Neuropathology Is Associated with Absence of Synaptic Tau Oligomers.

Singh A , Allen D , Fracassi A , Tumurbaatar B , Natarajan C , Scaduto P , Woltjer R , Kayed R , Limon A , Krishnan B , Taglialatela G .


Abstract
BACKGROUND: Certain individuals, here referred to as Non-Demented with Alzheimer Neuropathology (NDAN), do not show overt neurodegeneration (N-) and remain cognitively intact despite the presence of plaques (A+) and tangles (T+) that would normally be consistent with fully symptomatic Alzheimer''s disease (AD). OBJECTIVE: The existence of NDAN (A + T+N-) subjects suggests that the human brain utilizes intrinsic mechanisms that can naturally evade cognitive decline normally associated with the symptomatic stages of AD (A + T+N+). Deciphering the underlying mechanisms would prove relevant to develop complementing therapeutics to prevent progression of AD-related cognitive decline. METHODS: Previously, we have reported that NDAN present with preserved neurogenesis and synaptic integrity paralleled by absence of amyloid oligomers at synapses. Using postmortem brain samples from age-matched control subjects, demented AD patients and NDAN individuals, we performed immunofluorescence, western blots, micro transplantation of synaptic membranes in Xenopus oocytes followed by twin electrode voltage clamp electrophysiology and fluorescence assisted single synaptosome-long term potentiation studies. RESULTS: We report decreased tau oligomers at synapses in the brains of NDAN subjects. Furthermore, using novel approaches we report, for the first time, that such absence of tau oligomers at synapses is associated with synaptic functional integrity in NDAN subjects as compared to demented AD patients. CONCLUSION: Overall, these results give further credence to tau oligomers as primary actors of synaptic destruction underscoring cognitive demise in AD and support their targeting as a viable therapeutic strategy for AD and related tauopathies.

PubMed ID: 33185603
PMC ID: PMC7836055
Article link: J Alzheimers Dis
Grant support: [+]

Genes referenced: ctrl dlg4 psd

Disease Ontology terms: Alzheimer's disease
OMIMs: ALZHEIMER DISEASE, FAMILIAL, 1; AD1

Article Images: [+] show captions
References [+] :
Berger, Accumulation of pathological tau species and memory loss in a conditional model of tauopathy. 2007, Pubmed